INVO Bioscience, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
INVO Bioscience, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q2 2024.
  • INVO Bioscience, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 3.61M shares, a 393% increase year-over-year.
  • INVO Bioscience, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 1.57M shares, a 158% increase from 2022.
  • INVO Bioscience, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 606K shares, a 94.3% decline from 2021.
  • INVO Bioscience, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 10.6M shares, a 93.7% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 3.61M +2.88M +393% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 3.8M +3.18M +511% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 1.57M +960K +158% Oct 1, 2023 Dec 31, 2023 10-K/A 2024-04-17
Q3 2023 1.78M +1.17M +192% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 732K +126K +20.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 623K -11.4M -94.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 606K -10M -94.3% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-04-17
Q3 2022 608K -9.86M -94.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 606K -9.84M -94.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 12.1M +2.16M +21.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 10.6M +5.14M +93.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 10.5M +5.52M +112% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 10.4M +5.51M +112% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 9.89M +4.97M +101% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 5.49M +635K +13.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 4.95M +84.7K +1.74% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 4.93M -2.83M -36.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 4.92M -149M -96.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 4.85M -142M -96.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 4.86M -143M -96.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 7.76M -140M -94.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 154M +10.8M +7.51% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 147M +6.03M +4.27% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 147M +6.08M +4.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 147M +6.03M +4.27% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 143M +2.6M +1.84% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 141M Oct 1, 2017 Dec 31, 2017 10-K 2019-04-16
Q3 2017 141M +779K +0.55% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 141M +2.85M +2.06% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 141M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q3 2016 141M +7.36M +5.52% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 138M +12.9M +10.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-09-05
Q4 2015 129M +15.9M +14.1% Oct 1, 2015 Dec 31, 2015 10-K 2017-04-20
Q3 2015 133M +21.8M +19.6% Jul 1, 2015 Sep 30, 2015 10-Q 2017-09-05
Q2 2015 126M +14.2M +12.7% Apr 1, 2015 Jun 30, 2015 10-Q 2017-09-05
Q1 2015 120M +8.39M +7.53% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-17
Q4 2014 113M +5.62M +5.25% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-17
Q3 2014 111M +1.82M +1.66% Jul 1, 2014 Sep 30, 2014 10-K 2017-03-17
Q2 2014 111M +4.16M +3.88% Apr 1, 2014 Jun 30, 2014 10-K 2017-03-17
Q1 2014 111M +7.36M +7.07% Jan 1, 2014 Mar 31, 2014 10-K 2017-03-17
Q4 2013 107M +18M +20.2% Oct 1, 2013 Dec 31, 2013 10-K 2017-03-17
Q3 2013 110M +18.4M +20.2% Jul 1, 2013 Sep 30, 2013 10-K 2017-03-17
Q2 2013 107M +19.3M +22% Apr 1, 2013 Jun 30, 2013 10-K 2017-03-17
Q1 2013 104M +18.6M +21.8% Jan 1, 2013 Mar 31, 2013 10-K 2017-03-17
Q4 2012 89.1M Oct 1, 2012 Dec 31, 2012 10-K 2017-03-17
Q3 2012 91.2M +12.5M +15.9% Jul 1, 2012 Sep 30, 2012 10-K 2017-03-17
Q2 2012 87.9M +10.2M +13.1% Apr 1, 2012 Jun 30, 2012 10-K 2017-03-17
Q1 2012 85.4M Jan 1, 2012 Mar 31, 2012 10-K 2017-03-17
Q3 2011 78.6M +15M +23.6% Jul 1, 2011 Sep 30, 2011 10-Q 2011-11-21
Q2 2011 77.7M +16.2M +26.3% Apr 1, 2011 Jun 30, 2011 10-Q 2011-08-22
Q3 2010 63.6M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-21
Q2 2010 61.5M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.